Umeå Centre for Molecular Medicine (UCMM), Umeå University, Umeå, Sweden.
Wallenberg Centre for Molecular Medicine (WCMM), Umeå University, Umeå, Sweden.
Nat Commun. 2023 Oct 13;14(1):6446. doi: 10.1038/s41467-023-41919-x.
Chromatin organization controls transcription by modulating 3D-interactions between enhancers and promoters in the nucleus. Alterations in epigenetic states and 3D-chromatin organization result in gene expression changes contributing to cancer. Here, we map the promoter-enhancer interactome and regulatory landscape of glioblastoma, the most aggressive primary brain tumour. Our data reveals profound rewiring of promoter-enhancer interactions, chromatin accessibility and redistribution of histone marks in glioblastoma. This leads to loss of long-range regulatory interactions and overall activation of promoters, which orchestrate changes in the expression of genes associated to glutamatergic synapses, axon guidance, axonogenesis and chromatin remodelling. SMAD3 and PITX1 emerge as major transcription factors controlling genes related to synapse organization and axon guidance. Inhibition of SMAD3 and neuronal activity stimulation cooperate to promote proliferation of glioblastoma cells in co-culture with glutamatergic neurons, and in mice bearing patient-derived xenografts. Our findings provide mechanistic insight into the regulatory networks that mediate neurogliomal synaptic communication.
染色质组织通过调节核内增强子和启动子之间的 3D 相互作用来控制转录。表观遗传状态和 3D 染色质组织的改变导致基因表达变化,从而促进癌症的发生。在这里,我们绘制了神经胶质瘤的启动子-增强子互作组和调控图谱,神经胶质瘤是最具侵袭性的原发性脑肿瘤。我们的数据揭示了神经胶质瘤中启动子-增强子相互作用、染色质可及性和组蛋白标记重新分布的深刻重排。这导致长距离调控相互作用的丧失和启动子的整体激活,从而协调与谷氨酸能突触、轴突导向、轴突发生和染色质重塑相关基因的表达变化。SMAD3 和 PITX1 成为控制与突触组织和轴突导向相关基因的主要转录因子。SMAD3 抑制和神经元活性刺激的协同作用促进了与谷氨酸能神经元共培养以及携带患者来源异种移植物的小鼠中神经胶质瘤细胞的增殖。我们的研究结果为介导神经胶质瘤突触通讯的调控网络提供了机制见解。